
Opinion|Videos|October 14, 2024
Exploring the Kidney-CHAMP Study
Key Takeaways
- The trial focused on improving cardiovascular risk management in type 2 diabetes through a coordinated care model involving healthcare systems.
- Interventions included educational sessions, feedback, and support for healthcare providers to enhance adherence to guideline-directed medical therapy.
A panel of experts explores the objectives and design of the COORDINATE-Diabetes trial, discussing its potential impact on the treatment paradigm for diabetes management.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- Tell us about Kidney-CHAMP study.
- What were the objectives of Kidney-CHAMP and how was the study designed?
- What interventions were provided?
- What were the results of the study?
- What are future opportunities to improve CRM care based on this study?
This activity is supported by Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly and Company who provided financial support for this program.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Panel Backs 6 Peptides for Compounding
2
Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care
3
Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%
4
FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies
5





